Oferta Tecnológica

En este espacio publicaremos la Oferta Tecnológica del CIBERFES cuando esté disponible.

CIBERER pone a disposición su cartera tecnológica de patentes susceptibles de explotación:

• New compounds for the treatment of Type 2 Diabetes and otherdiseases by modulation of the enzymatic complex AMPKdiseases by modulation of the enzymatic complex AMPK indol
• Experimental models for studying rare diseases
  
• OT - Bioengineered Skin for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
• METHODS FOR INCREASING DNA COPY NUMBER
  
• New Therapy for the treatment of epidermolysis bullosa
  
• IMPROVEMENTS FOR PERMORFING AND FACILITATING THE RECOVERY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
  
• Methods for the measurement of Protein C and Activated Protein C
• Pharmaceutical compositions for the treatment of Charcot-Marie-Tooth disease
• Ex vivo gene therapy approach in Diamond Blackfan Anemia (DBA)
• In vivo lentiviral gene therapy for the treatment of Primary Hyperoxaluria Type-1
• Genetically modified mesenchymal stromal cells to treat graft versus hot disease (GVHD)
  
• Aptamers For The Treatment Of Congenital and Acquired Neutropenias
•  Gene editing for the treatment of Ewing’s Sarcoma

• High reliability prediction of fluid/vascular responses and estimation of pleural pressure changes in patients
• Detection of Tuberculosis in urine samples by a specific metabolic signature
• Early prognosis of Tako-Tsubo cardiomyopathy in patients with aneurysmal subarachnoid haemorrhage
• Mortality prediction in COVID-19 patients
• Carvacrol as disinfectant against Legionella
• Prediction of Acute Respiratory Distress in COVID19 patients
• Biomarkers to predict lung overstretching

En este espacio podrá consultar nuestra oferta y demanda tecnológica abierta a la colaboración con la empresa.

• Capacidades Tecnológicas

  • NewroPharma. Programa de Innovación terapéutica

• Patentes

  • A kit for predicting the therapeutic response to antipsychotic drugs
    
  • Bilateral pupillometry platform for small animals
  • Highly biocompatible extracellular vesicles from sustainable sources

• Precision medicine for the treatment of obesity
• Prevention and/or treatment of a mental disorder with memory impairment in a subject by using microbiota composition
• Bacteriophague for the prevention and treatment of a mental disorders
• Biomarcadores epigenéticos para el diagnóstico y prevención de la evolución de la obesidad

Oferta tecnológica del CIBEREHD:

• Biosignatures for ulcerative colitis
  
• Non-invasive method for the diagnosis of colorectal cancer
  
• Saliva-based diagnostic test for eosinophilic oesophagitis
• Informative biomarkers of portal hypertension.
• Compounds for treating Helicobacter pylori and Campylobacter jejuni infection.

• Biomarcadores y método diagnóstico de la MODY NHF1A

• Improved glucose monitoring during exercise using wearable devices

• An e-infrastructure based on Cloud and Edge Computing for data analysis in metabolomics 

• Biomarcadores epigenéticos para el diagnóstico y prevención de la evolución de la obesidad

• METADISC 2.0 Software for meta-analysis of test accuracy data.

En este espacio publicaremos la Oferta Tecnológica del CIBERINFEC cuando esté disponible.

• Dream Neuronal Calcium Sensor-Modulating Compounds, and Therapeutic Uses Thereof.
• Circulating Mirnas as Biomarkers For Diagnosis of Mild Cognitive Impairment and Alzheimer´S Disease.
• Combined Use Of Biotine and Thiamine for Prevention and Treatment of Hungtington Disease.
• Method for Diagnosis, Prognosis and Monitoring of Alzheimer Disease Using Metabolomic Techniques.
• Alzheimer's Disease Diagnostic Biomarker, a Method And Kit Based.

En este espacio publicaremos la Oferta Tecnológica del CIBERCV cuando esté disponible 

• USE OF AN MNK kinase inhibitor for the treatment of Triple-negative breast cancer
  
• New Predictive method for the progression of colorectal cancer
• Biomarcadores para predecir la respuesta al tratamiento de pacientes con melanoma metastásico